59 results
8-K
EX-99.1
ATHA
Athira Pharma Inc
17 May 24
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
5:00pm
settlement calls for Athira to adopt certain corporate governance reforms and pay lead plaintiffs’ attorney’s fees, litigation expenses, and lead
8-K
ATHA
Athira Pharma Inc
17 May 24
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
5:00pm
settlement calls for the Company to adopt certain corporate governance reforms and pay lead plaintiffs’ attorney’s fees, litigation expenses, and lead
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
AND CORPORATE GOVERNANCE
Composition of the Board of Directors
Nominees for Director
Continuing Directors
Director Independence
Board Leadership Structure … and Governance (ESG) and Related Matters
Director Compensation
PROPOSAL NO. 1: ELECTION OF CLASS I DIRECTORS
Nominees
Vote Required
Board
8-K
zc7 k7ggw990e
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-3.1
cdjnzio2v0pv6w
18 Nov 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
DFAN14A
EX-99.1
baz2 wfbzibdys9ai
12 May 22
Additional proxy materials by non-management
2:06pm
DFAN14A
EX-99.1
f5ed 7x8455do
5 May 22
Additional proxy materials by non-management
11:00am
DFAN14A
EX-99.2
smb19z jw698
27 Apr 22
Additional proxy materials by non-management
2:39pm
DFAN14A
EX-99.1
2baq5 ze6irkbzp188t7
27 Apr 22
Additional proxy materials by non-management
2:39pm